A Pressing Public Health Challenge in Europe
Diabetic retinopathy (DR) is one of the leading causes of preventable vision impairment and blindness in Europe. With the ongoing rise in diabetes prevalence across the region, healthcare systems face increasing pressure to detect DR early and manage it effectively.
According to the World Health Organization (WHO), an estimated 950,000 people in the WHO European Region have vision impairment or blindness due to diabetic retinopathy — highlighting the critical need for systematic retinal screening. World Health Organization
📍Explore product
Understanding the European Problem: Diabetes & Retinal Disease
Diabetes Prevalence
Across the WHO European Region, approximately 64 million people — about 7 % of the population — live with diabetes, many of whom remain at risk for DR. World Health Organization
DR Prevalence Among People with Diabetes
Studies show that between 20 % and 35 % of people with diabetes in Europe develop some form of diabetic retinopathy during their lifetime — making DR a widespread and often asymptomatic condition that can progress silently. International Diabetes Federation
Impact of Untreated DR
Because early DR often shows no symptoms, delays in diagnosis can lead to irreversible vision loss. Even in high-income settings with strong health infrastructure, screening coverage remains inconsistent and many patients are not identified early enough to prevent vision impairment. World Health Organization
Why Traditional Screening Falls Short
Historically, DR screening has relied on tabletop fundus cameras installed in hospitals or specialist centres. While clinically accurate, these devices present several challenges:
- Limited accessibility for patients outside urban hubs
- Dependency on specialist operators
- Need for dedicated exam rooms and significant infrastructure
- Long wait times for appointments in public systems
These limitations create barriers for high-risk populations — particularly in rural areas, community clinics, and GP practices.
Portable Fundus Cameras: A Transformative Solution
Portable fundus cameras are changing the landscape of retinal screening by enabling:
1. Point-of-Care Retinal Imaging
Portable devices can be used directly in primary care settings, diabetes clinics, and outreach programs — bringing screening closer to patients.
2. Non-mydriatic Imaging
Many portable fundus cameras can capture high-quality retinal images without pupil dilation, making the screening process faster and more comfortable for patients.
3. Telemedicine-Enabled Workflows
Retinal images captured in the field can be shared with ophthalmologists or reading centres remotely, supporting tele-ophthalmology screening models that reduce bottlenecks in specialist review.
4. Cost-Effective Scaling
Compared with traditional tabletop systems, portable fundus cameras require far less infrastructure and can be deployed across multiple locations, making them ideal for nationwide or regional screening initiatives.
📍Request a Demo
Clinical and Public Health Benefits for Europe
1. Increase Screening Coverage
By taking screening to the point of care, portable fundus cameras help ensure more people with diabetes are examined regularly — a key factor in preventing vision loss.
2. Reduce Specialist Burden
Technicians and trained non-specialist staff can capture retinal images, allowing ophthalmologists to focus on diagnosis and treatment planning.
3. Support Early Diagnosis and Referral
With quick image acquisition and remote interpretation, patients with early signs of DR can be identified and referred promptly — reducing the risk of progression.
Use Cases Across the European Healthcare Ecosystem
📍 Primary & Community Care Centres
GPs and diabetes clinics can integrate portable retinal imaging into routine check-ups.
📍 Optometry and Optician Networks
Screening at optometry locations helps identify DR early in patients who seek vision exams but may not attend specialist appointments.
📍 Mobile Health Units
NGOs and public health initiatives can deploy portable fundus cameras in mobile vans to reach underserved rural populations.
📍 Nursing Homes & Home Care
Elderly patients with mobility limitations can be screened on-site without the need for hospital visits.
Why Remidio’s Portable Fundus Camera Is the Right Choice
Remidio’s portable fundus camera is engineered for real-world screening in diverse healthcare settings, offering:
- Lightweight and battery-ready design for mobile use
- High-quality non-mydriatic retinal imaging
- Smartphone-integrated workflow for instant image capture and sharing
- Tele-ophthalmology compatibility for remote interpretation
- Proven clinical effectiveness in large screening programs
These features make it an excellent solution for European healthcare providers striving to expand DR screening access and improve patient outcomes.
📍chat with our medical expert
Conclusion: A Vision for Preventable Blindness
With diabetes on the rise across Europe, the need for accessible and scalable diabetic retinopathy screening has never been greater. Portable fundus cameras offer a practical and efficient solution — enabling earlier diagnosis, broader coverage, and better patient care.
By integrating portable retinal imaging into clinical workflows, healthcare providers can help prevent avoidable vision loss and build stronger, more resilient eye-care systems.
👉 Learn how Remidio’s Portable Fundus Camera can support your diabetic retinopathy screening program — click to explore!